Photodynamic Therapy in Treating Patients With Lymphoma or Chronic Lymphocytic Leukemia
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
RATIONALE: Photodynamic therapy uses light and drugs that make cancer cells more sensitive to
light to kill cancer cells. Photosensitizing drugs such as aminolevulinic acid are absorbed
by cancer cells and, when exposed to light, become active and kill the cancer cells.
PURPOSE: Randomized phase II trial to study the effectiveness of photodynamic therapy using
aminolevulinic acid in treating patients who have cutaneous T-cell lymphoma, B-cell lymphoma,
or early chronic lymphocytic leukemia involving the skin.